Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 2Gynecologic 2Thoracic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 71Lung Neoplasms 32Triple Negative Breast Neoplasms 23Breast Neoplasms 19Small Cell Lung Carcinoma 15Ovarian Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Endometrial Neoplasms 13Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 10Fallopian Tube Neoplasms 10Neoplasm Metastasis 9Colorectal Neoplasms 6Urinary Bladder Neoplasms 5Carcinoma 5Adenocarcinoma of Lung 5Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pathologic Complete Response 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mesothelioma 3Melanoma 3Lung Diseases 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Central Nervous System Neoplasms 3Uterine Neoplasms 2Thoracic Neoplasms 2Sarcoma 2

Interventions

Cisplatin 6Paclitaxel 4pembrolizumab 3Fluorouracil 3Carboplatin 3tislelizumab 2Taxes 2Radiotherapy 2Oxaliplatin 2Leucovorin 2Irinotecan 2Injections 2Capecitabine 2130-nm albumin-bound paclitaxel 2spartalizumab 1lenvatinib 1durvalumab 1cixutumumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Saline Solution 1Radiation 1Levoleucovorin 1Laparoscopy 1Histamine H2 Antagonists 1Histamine Antagonists 1Fulvestrant 1Docetaxel 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Carboplatin × 30 days × Clear all
NCT06535607 2026-05-26

eVOLVE-02

AstraZeneca

Phase 2 Recruiting
257 enrolled
GastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms

NCT07595770 2026-05-19

ANCRE

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
37 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04389632 2026-05-11

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Seagen Inc.

Phase 1 Recruiting
1,006 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡